Filing Details

Accession Number:
0001365618-15-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-12 16:59:00
Reporting Period:
2015-11-10
Filing Date:
2015-11-12
Accepted Time:
2015-11-12 16:59:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365618 D Anders Hove C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-10 100,295 $103.60 1,598,517 No 4 S Indirect By Funds and LLC's
Common Stock Disposition 2015-11-10 372,982 $0.00 1,225,535 No 4 J Indirect By Funds and LLC's
Common Stock Acquisiton 2015-11-10 73,092 $0.00 73,886 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Funds and LLC's
No 4 J Indirect By Funds and LLC's
No 4 J Direct
Footnotes
  1. Following the sale, the shares are held as follows: 566,247 shares held by Venrock Associates IV, L.P. ("VA4"), 115,475 shares held by Venrock Partners, L.P. ("VP"), 13,913 shares held by Venrock Entreprenerus Fund IV, L.P. ("VEF4"), 447,957 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), 81,943 shares held by VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), 180,193 shares held by Venrock Management IV, LLC ("VM4"), 36,797 shares held by Venrock Partners Management, LLC ("VPM"), 3,502 shares held by VEF Management IV, LLC ("VEFM4") and 152,490 shares held by VHCP Management, LLC (" VHCP Management").
  2. VM4, VPM and VEFM4 are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein.
  3. On November 10, 2015, VM4, VPM, VEFM4 and VHCP Management distributed an aggregate of 372,982 shares of the common stock of the Issuer to their respective partners pro rata based on their respective interests (the "Distribution").
  4. Following the Distribution, the shares are held as follows: 566,247 shares held by VA4, 115,475 shares held by VP, 13,913 shares held by VEF4, 447,957 shares held by VHCP, and 81,943 shares held by VHCP Co-Invest.
  5. In the Distribution, Dr. Hove received an aggregate of 73,092 shares through his ownership interests in the Venrock entities. For Dr. Hove, this represents a change in form of ownership from indirect to direct but does not represent a change in beneficial ownership.
  6. The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold an aggregate of 794 of the reported securities for the sole benefit of the Management Company (the "Management Company Shares"). The Management Company may be deemed the indirect beneficial owner of the Management Company Shares, and the reporting person may be deemed the indirect beneficial owner of the Management Company Shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the Management Company Shares except to the extent of his indirect pecuniary interest therein.